nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—Pharyngeal oedema—Cyclosporine—focal segmental glomerulosclerosis	0.0672	0.0724	CcSEcCtD
Salicylate-sodium—Renal tubular necrosis—Cyclosporine—focal segmental glomerulosclerosis	0.0537	0.0579	CcSEcCtD
Salicylate-sodium—Swelling face—Cyclosporine—focal segmental glomerulosclerosis	0.0403	0.0434	CcSEcCtD
Salicylate-sodium—Gastric ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.033	0.0356	CcSEcCtD
Salicylate-sodium—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.0276	0.0298	CcSEcCtD
Salicylate-sodium—Coagulopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0247	0.0266	CcSEcCtD
Salicylate-sodium—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.0245	0.0263	CcSEcCtD
Salicylate-sodium—Abscess—Cyclosporine—focal segmental glomerulosclerosis	0.0243	0.0261	CcSEcCtD
Salicylate-sodium—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.0239	0.0257	CcSEcCtD
Salicylate-sodium—Stinging—Cyclosporine—focal segmental glomerulosclerosis	0.0237	0.0255	CcSEcCtD
Salicylate-sodium—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.0211	0.0227	CcSEcCtD
Salicylate-sodium—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.0202	0.0217	CcSEcCtD
Salicylate-sodium—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.0202	0.0217	CcSEcCtD
Salicylate-sodium—PTGS2—nephron—focal segmental glomerulosclerosis	0.0195	0.425	CbGeAlD
Salicylate-sodium—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.0182	0.0196	CcSEcCtD
Salicylate-sodium—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.0181	0.0195	CcSEcCtD
Salicylate-sodium—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.0175	0.0189	CcSEcCtD
Salicylate-sodium—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.0167	0.0179	CcSEcCtD
Salicylate-sodium—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.0156	0.0168	CcSEcCtD
Salicylate-sodium—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.0156	0.0168	CcSEcCtD
Salicylate-sodium—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.0146	0.0158	CcSEcCtD
Salicylate-sodium—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.0142	0.0153	CcSEcCtD
Salicylate-sodium—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.0131	0.0141	CcSEcCtD
Salicylate-sodium—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.0127	0.0137	CcSEcCtD
Salicylate-sodium—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.0121	0.0131	CcSEcCtD
Salicylate-sodium—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.012	0.013	CcSEcCtD
Salicylate-sodium—Magnesium salicylate—ALB—focal segmental glomerulosclerosis	0.012	0.463	CrCbGaD
Salicylate-sodium—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.0118	0.0128	CcSEcCtD
Salicylate-sodium—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.0117	0.0126	CcSEcCtD
Salicylate-sodium—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.0116	0.0125	CcSEcCtD
Salicylate-sodium—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0115	0.0124	CcSEcCtD
Salicylate-sodium—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.011	0.0118	CcSEcCtD
Salicylate-sodium—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.0106	0.0114	CcSEcCtD
Salicylate-sodium—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.0106	0.0114	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.0105	0.0113	CcSEcCtD
Salicylate-sodium—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.0101	0.0109	CcSEcCtD
Salicylate-sodium—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00964	0.0104	CcSEcCtD
Salicylate-sodium—PTGS1—endothelium—focal segmental glomerulosclerosis	0.0096	0.21	CbGeAlD
Salicylate-sodium—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00959	0.0103	CcSEcCtD
Salicylate-sodium—PTGS2—endothelium—focal segmental glomerulosclerosis	0.00918	0.2	CbGeAlD
Salicylate-sodium—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00899	0.00968	CcSEcCtD
Salicylate-sodium—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00861	0.00928	CcSEcCtD
Salicylate-sodium—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00827	0.00891	CcSEcCtD
Salicylate-sodium—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00822	0.00885	CcSEcCtD
Salicylate-sodium—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00791	0.00852	CcSEcCtD
Salicylate-sodium—Acetylsalicylic acid—ALB—focal segmental glomerulosclerosis	0.0076	0.294	CrCbGaD
Salicylate-sodium—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00727	0.00783	CcSEcCtD
Salicylate-sodium—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00714	0.0077	CcSEcCtD
Salicylate-sodium—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00712	0.00767	CcSEcCtD
Salicylate-sodium—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00691	0.00744	CcSEcCtD
Salicylate-sodium—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00685	0.00738	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00685	0.00738	CcSEcCtD
Salicylate-sodium—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.0068	0.00733	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00662	0.00713	CcSEcCtD
Salicylate-sodium—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00653	0.00703	CcSEcCtD
Salicylate-sodium—Salicylic acid—ALB—focal segmental glomerulosclerosis	0.00626	0.242	CrCbGaD
Salicylate-sodium—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00615	0.00662	CcSEcCtD
Salicylate-sodium—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00611	0.00658	CcSEcCtD
Salicylate-sodium—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00609	0.00656	CcSEcCtD
Salicylate-sodium—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00603	0.00649	CcSEcCtD
Salicylate-sodium—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00595	0.00641	CcSEcCtD
Salicylate-sodium—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.0059	0.00636	CcSEcCtD
Salicylate-sodium—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00586	0.00631	CcSEcCtD
Salicylate-sodium—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00586	0.00631	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00564	0.00608	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.0056	0.00603	CcSEcCtD
Salicylate-sodium—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00544	0.00586	CcSEcCtD
Salicylate-sodium—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00541	0.00583	CcSEcCtD
Salicylate-sodium—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00541	0.00583	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00505	0.00543	CcSEcCtD
Salicylate-sodium—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00491	0.00529	CcSEcCtD
Salicylate-sodium—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00485	0.00522	CcSEcCtD
Salicylate-sodium—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00469	0.00505	CcSEcCtD
Salicylate-sodium—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00453	0.00488	CcSEcCtD
Salicylate-sodium—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00435	0.00469	CcSEcCtD
Salicylate-sodium—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00432	0.00465	CcSEcCtD
Salicylate-sodium—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00431	0.00465	CcSEcCtD
Salicylate-sodium—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00429	0.00462	CcSEcCtD
Salicylate-sodium—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00407	0.00438	CcSEcCtD
Salicylate-sodium—PTGS1—kidney—focal segmental glomerulosclerosis	0.00386	0.0844	CbGeAlD
Salicylate-sodium—PTGS2—kidney—focal segmental glomerulosclerosis	0.00369	0.0807	CbGeAlD
